CompanyGraph
At a glance
- Depends onMidstream position: 5 outgoing, 4 incoming connections
- ScaleRevenue is $18.17M, lower than 95% of all stocks globally
- FinancialsHigh structural barrier to entry
- Interpretations1 currently firing — 1
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
0.16%
Annual Rate
INR 0.67Paid unknown
Payout Ratio
15.0%Sustainable
Last Ex-Dividend
Sep 23, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
53.58BINR560.47M · vs all stocks (USD)
Trailing P/E
92.22xRevenue (TTM)
1.74BINR18.17M · vs all stocks (USD)
Profit Margin
28.02%Beta
0.5050xvs all stocks
52-Week Change
-0.33%vs all stocks
Forward Annual Dividend Yield
0.16%vs all stocks
Market Capitalization
53.58BINR560.47M · vs all stocks (USD)
Enterprise Value
48.13BINR503.48M · vs all stocks (USD)
Trailing P/E
92.22xPEG Ratio
4.03xPrice to Sales (TTM)
31.02xPrice to Book (MRQ)
15.68xEnterprise to Revenue
27.70xEnterprise to EBITDA
58.22xGross Margin
87.70%Profit Margin
28.02%Operating Margin
38.41%Return on Assets (TTM)
9.27%Return on Equity (TTM)
16.22%Revenue (TTM)
1.74BINR18.17M · vs all stocks (USD)
Revenue per Share (TTM)
15.95INRUpdated Sep 23, 2026Quarterly Revenue Growth
22.10%Gross Profit (TTM)
1.16BINR12.17M · vs all stocks (USD)
EBITDA (TTM)
846.88MINR8.86M · vs all stocks (USD)
Net Income (TTM)
486.87MINR5.09M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
22.10%Operating Cash Flow (TTM)
487.77MINR5.10M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
466.81MINR4.88M · vs all stocks (USD)
Forward Annual Dividend Rate
0.6700INRUpdated Sep 23, 2026Forward Annual Dividend Yield
0.16%vs all stocks
Trailing Annual Dividend Rate
0.00INRUpdated Sep 23, 2026Trailing Annual Dividend Yield
0.00%vs all stocks
Payout Ratio
14.99%Revenue
1.66BINRFY2026 · Mar 31, 2026Cost of Goods Sold
275.79MINRFY2026 · Mar 31, 2026Gross Profit
1.38BINRFY2026 · Mar 31, 2026Operating Income
626.11MINR6.55M · vs all stocks (USD)
Pre-tax Income
620.90MINRFY2026 · Mar 31, 2026Income Tax Expense
154.09MINRFY2026 · Mar 31, 2026Net Income
466.87MINRFY2026 · Mar 31, 2026EBIT
650.39MINRFY2026 · Mar 31, 2026EBITDA (Income Statement)
779.58MINRFY2026 · Mar 31, 2026Other Operating Expenses
462.03MINRFY2026 · Mar 31, 2026Non-operating Interest Expense
29.49MINRFY2026 · Mar 31, 2026Preferred Stock Dividends
0.00INRFY2026 · Mar 31, 2026Operating Cash Flow
240.31MINRFY2026 · Mar 31, 2026Free Cash Flow
-1.49BINRFY2026 · Mar 31, 2026Cash & Cash Equivalents (End of Period)
31.21MINRFY2026 · Mar 31, 2026Starting Profit (CF Statement)
620.90MINRFY2026 · Mar 31, 2026Other Non-cash Items
24.55MINRFY2026 · Mar 31, 2026Change in Accounts Receivable (CF)
-296.78MINRFY2026 · Mar 31, 2026Change in Other Assets/Liabilities
-108.36MINRFY2026 · Mar 31, 2026Capital Expenditures
-1.73BINRFY2026 · Mar 31, 2026Net Investing Cash Flow
-1.73BINRFY2026 · Mar 31, 2026Long-term Debt Issuance
1.30BINRFY2026 · Mar 31, 2026Common Dividends Paid
-73.01MINRFY2026 · Mar 31, 2026Net Financing Cash Flow
1.23BINRFY2026 · Mar 31, 2026Shares Outstanding
130.15MSharesUpdated Sep 23, 2026Float Shares
42.78MSharesUpdated Sep 23, 2026% Held by Insiders
60.27%vs all stocks
% Held by Institutions
3.16%vs all stocks
Total Cash (MRQ)
60.88MINR636.82K · vs all stocks (USD)
Total Cash per Share (MRQ)
0.5590INRUpdated Sep 23, 2026Total Debt (MRQ)
1.62BINR16.93M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.5623xCurrent Ratio (MRQ)
1.12xBook Value per Share (MRQ)
26.41INRUpdated Sep 23, 2026Total Assets
5.03BINR52.66M · vs all stocks (USD)
Total Current Assets
887.84MINRFY2026 · Mar 31, 2026Total Liabilities
2.16BINRFY2026 · Mar 31, 2026Total Non-current Assets
4.15BINRFY2026 · Mar 31, 2026Total Non-current Liabilities
1.37BINRFY2026 · Mar 31, 2026Total Current Liabilities
791.48MINRFY2026 · Mar 31, 2026Cash & Cash Equivalents
31.21MINRFY2026 · Mar 31, 2026Other Short-term Investments
32.97MINRFY2026 · Mar 31, 2026Accounts Receivable
609.17MINRFY2026 · Mar 31, 2026Inventory
154.23MINRFY2026 · Mar 31, 2026Accounts Payable
366.54MINRFY2026 · Mar 31, 2026Short-term Debt
330.97MINRFY2026 · Mar 31, 2026Other Current Liabilities
30.54MINRFY2026 · Mar 31, 2026Long-term Debt
1.29BINRFY2026 · Mar 31, 2026Common Stock (Book)
108.97MINRFY2026 · Mar 31, 2026Total Shareholders' Equity
2.88BINR30.10M · vs all stocks (USD)
52-Week Low
225.05INRUpdated Sep 23, 202652-Week High
479.00INRUpdated Sep 23, 202652-Week Change
-0.33%vs all stocks
Beta
0.5050xvs all stocks
50-Day MA
385.70INRUpdated Sep 23, 2026200-Day MA
359.48INRUpdated Sep 23, 2026Avg 10-Day Volume
655.35KSharesUpdated Sep 23, 2026Avg 30-Day Volume
575.14KSharesUpdated Sep 23, 2026Diluted EPS (TTM)
4.49INRUpdated Sep 23, 20261 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsWhere is this company structurally exposed?
Receivables Heavy and Growing
Money owed by customers keeps growing, and is much of its current assets.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
High structural barrier to entryNotable
Barrier to Entry: 0.70
Supply Chain
Midstream position: 5 outgoing, 4 incoming connectionsNotable
Outgoing: 5.00Incoming: 4.00
Scale
Revenue is $18.17M, lower than 95% of all stocks globallySignificant
Revenue (USD): 18,174,931.357Global P5: 33,357,653.812
Companies that share the same coordination system — how they create, deliver, or capture value.
Nanjing Hicin Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Beijing Scitop Bio-Tech Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Guangdong Transtek Medical Co. Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Nanjing Well Pharmaceutical Group Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Neurogene Inc.
Tier 1ProductionApproval-Gated PipelineRule
Zhejiang Starry Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Allogene Therapeutics Inc.
Tier 1ProductionApproval-Gated PipelineRuleRisk
Shanghai General Healthy Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Assure Tech Hangzhou Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Zhejiang Orient Gene Biotech Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Companies that share active interpretations — structural patterns currently present in both stocks.
Fischer Medical Ventures Ltd
1 interpretationReceivables Heavy and Growing
Cecep Environmental Protection Co. Ltd.
1 interpretationReceivables Heavy and Growing
Shanghai Yanpu Metal Products Co. Ltd.
1 interpretationReceivables Heavy and Growing